The most frequently mutated gene in plasma was TP53 with a frequency of 33.8% in the total cohort and an enrichment in SqCC and SCLC (46.7% and 50.0%, respectively), compared to AC (31.6%). The gene discussed is TP53; the disease is small cell lung carcinoma.